Mentholated Bronchial Balsam oral solution

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Levomenthol; Squill tincture; Liquorice liquid extract

Available from:

Thornton & Ross Ltd

ATC code:

R05CA10

INN (International Name):

Levomenthol; Squill tincture; Liquorice liquid extract

Dosage:

800microgram/1ml ; 120microlitre/1ml ; 25microlitre/1ml

Pharmaceutical form:

Oral solution

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Never Valid To Prescribe As A VMP

Product summary:

BNF: ; GTIN: 5011309078626

Patient Information leaflet

_MENTHOLATED_
_Broncold_
_SYRUP_
™
_MENTHOLATED_
DOSAGE:
LIQUID FOR ORAL USE.
Adults and children over 12 years:
Take two or three 5ml spoonfuls
(10ml to 15ml).
Children from 6 to 12 years:
Take one
or two 5ml spoonfuls (5ml to 10ml).
The above doses may be taken
every 2 or 3 hours.
DO NOT GIVE TO CHILDREN UNDER 6 YEARS.
WARNINGS:
Do not use if you are allergic to any
of the ingredients.
Consult your doctor or pharmacist before
use if you are pregnant or breast-feeding.
If you have been told by your doctor that you
have an intolerance to some sugars, contact
your doctor before using this medicinal product.
Contains 1.9g of sucrose per 15ml dose.
This should be taken into account in patients
with diabetes mellitus.
This product contains 2.6 vol% ethanol
(alcohol), i.e. up to 306mg per 15ml dose,
equivalent to 7.7ml of beer or 3.2ml of wine
per 15ml dose. Harmful for those suffering
from alcoholism. To be taken into account in
pregnant or breast-feeding women, children
and high-risk groups such as patients with
liver disease or epilepsy.
SIDE EFFECTS
This medicine has no known side effects
REPORTING OF SIDE EFFECTS
If you get any side effects, talk to your doctor,
pharmacist or nurse. This includes any possible
side effects not listed on this carton. You can
also report side effects directly via the Yellow
Card Scheme at www.yellowcard.mhra.gov.uk
or search for MHRA Yellow Card in the Google
Play or Apple App Store. By reporting side
effects you can help provide more information
on the safety of this medicine.
BRONCOLD
™ SYRUP
MENTHOLATED, 200ML e
_Broncold_
_SYRUP_
™
_Menthol, Aniseed Oil_
_& Capsicum Tincture_
for relief of
Sore Throats,
Coughs, Colds
& Catarrh
_Non Drowsy_
200ML
e
_Menthol, Aniseed Oil_
_& Capsicum Tincture_
for relief of
Sore Throats,
Coughs, Colds
& Catarrh
_Non Drowsy_
200ML
e
Broncold
Syrup
Mentholated
EXPIRY DATE AND BATCH NO.
SEE LABEL AND BASE OF CARTON.
Keep out of the sight and reach of children
Do not store above 25
˚
C
H
EALTH
A
ID
L
TD
HealthAid House, Marlborough Hill,
Harrow

Summary of Product characteristics

1
NAME OF THE MEDICINAL PRODUCT
Asda Mentholated Bronchial Balsam
Bell’s Healthcare Mentholated Bronchial Balsam Oral Solution
Broncold™ Syrup Mentholated
Essential Waitrose Mentholated Bronchial Balsam Oral Solution
Fitzroy Mentholated Koff & Kold Syrup (Export Only)
Friar Tuck's Herbal Bronchial Balsam
Gordons Chesty Cough Linctus Oral Solution
Numark Mentholated Bronchial Balsam
Sainsbury’s Bronchial Balsam Oral Solution
Superdrug Bronchial Balsam Oral Solution
Tesco Health Mentholated Bronchial Balsam Oral Solution
The co-operative Mentholated Bronchial Balsam Oral Solution
Wilko Mentholated Bronchial Balsam
Lloyds Pharmacy Mentholated Bronchial Balsam Oral Solution
Well Pharmaceuticals Mentholated Bronchial Balsam Oral Solution
Morrisons Mentholated Bronchial Balsam Oral Solution
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 5 ml contains:
Levomenthol BP
1.0 mg
Aniseed Oil BP
0.0035 ml
Capsicum Tincture BPC
0.025 ml
3.
PHARMACEUTICAL FORM
Oral Solution
4
CLINICAL PARTICULARS
4.1.
THERAPEUTIC INDICATIONS
For the symptomatic relief of sore throats, coughs, colds and catarrh.
4.2.
POSOLOGY AND METHOD OF ADMINISTRATION
Oral
Either
a)
Adults
Children 6 to 12 years
Children 3 to 6 years
10 ml every hour
5 ml every hour
5 ml every 2 hours
Or
b)
Adults
Children 6 to 12 years
Elderly
10 ml or 15 ml every 2 or 3 hours
5 ml or 10 ml every 2 or 3 hours
As adults
4.3.
CONTRA-INDICATIONS
None stated
4.4.
SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE
None stated
4.5.
INTERACTIONS
WITH
OTHER
MEDICINAL
PRODUCTS
AND
OTHER
FORMS
OF
INTERACTION
None stated
4.6.
PREGNANCY AND LACTATION
None stated
4.7.
EFFECTS ON ABILITY TO DRIVE AND USE MACHINES
None stated
_4.8 _
_UNDESIRABLE EFFECTS _
_None stated _
_ _
_ Reporting of suspected adverse reactions _
Reporting suspected adverse reactions after authorisation of the
medicinal
product is important. It allows continued monitoring of the
benefit/risk balance
of the medicinal product. Healthcare professionals are asked to report
any
suspected adverse reactions via the Yello